200,000+ products from a single source!

sales@angenechem.com

Home > Other Heterocycles > 124378-77-4

124378-77-4

124378-77-4 | 4-Benzofuranacetamide, N-methyl-N-[(5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-

CAS No: 124378-77-4 Catalog No: AG000LY1 MDL No:MFCD00897252

Product Description

Catalog Number:
AG000LY1
Chemical Name:
4-Benzofuranacetamide, N-methyl-N-[(5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-
CAS Number:
124378-77-4
Molecular Formula:
C24H32N2O3
Molecular Weight:
396.5225
MDL Number:
MFCD00897252
IUPAC Name:
2-(1-benzofuran-4-yl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide
InChI:
InChI=1S/C24H32N2O3/c1-25(23(27)16-18-6-4-7-22-19(18)9-15-28-22)20-8-11-24(10-5-14-29-24)17-21(20)26-12-2-3-13-26/h4,6-7,9,15,20-21H,2-3,5,8,10-14,16-17H2,1H3/t20-,21-,24-/m0/s1
InChI Key:
JMBYBVLCYODBJQ-HFMPRLQTSA-N
SMILES:
O=C(N([C@H]1CC[C@]2(C[C@@H]1N1CCCC1)CCCO2)C)Cc1ccc2c(o1)ccc2
UNII:
KJL283326C

Properties

Complexity:
593  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0
Exact Mass:
396.241g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
396.531g/mol
Monoisotopic Mass:
396.241g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
45.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.4  

Literature

Title Journal
Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms. Psychopharmacology 20100601
Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys. European journal of pharmacology 20071208
Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. The Journal of pharmacology and experimental therapeutics 20071101
Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose 'binge' cocaine administration paradigm. Synapse (New York, N.Y.) 20071001
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands. Journal of medicinal chemistry 20050728
Modification of kappa-opioid receptor agonist-induced antinociception by diabetes in the mouse brain and spinal cord. Journal of pharmacological sciences 20050501
Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors. Journal of medicinal chemistry 20031120
Long-term effects on brain opioid and opioid receptor like-1 receptors after short periods of maternal separation in rats. Neuroscience letters 20030724
Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain research 20020726
Sex and rat strain determine sensitivity to kappa opioid-induced antinociception. Psychopharmacology 20020301
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. The Journal of pharmacology and experimental therapeutics 20011001
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology 20010901
Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene. Brain research 20010706
Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists. The Journal of pharmacology and experimental therapeutics 20010401
Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice. European journal of pharmacology 20010302
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat. British journal of pharmacology 19991201
The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents. Journal of neural transmission (Vienna, Austria : 1996) 19980101
Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor. Molecular pharmacology 19961001
CI-977, a novel and selective agonist for the kappa-opioid receptor. British journal of pharmacology 19900901

Related Products

© 2019 Angene International Limited. All rights Reserved.